Nomar Medical Starts Approval Trials

Nomir Medical Technologies Inc. of Waltham, Mass., a medical device company, has announced the initiation of the product registration trial for its Noveon direct optical energy device. The objective is to gain FDA approval for using the product in treating patients with onychomycosis. The company received 501(k) clearance in November 2007 to use the device during surgical procedures of the skin, subcutaneous tissues and nasal passages.





LATEST NEWS

• The Winds of Change Are Blowing Through the Photonics Industry
  May 3, 2024
• PsiQuantum to Build Utility-Scale Quantum Computer in Australia
  May 3, 2024
• Tyndall, MIT Partner on Sustainable Chip Production Processes: Week in Brief: 5/3/24
  May 3, 2024
• Headwall Taps Jim Gareau to Lead Optical Components and Assemblies Unit
  May 2, 2024
• Cognex Names Former Siemens VP Dennis Fehr CFO
  May 2, 2024
• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024